Capillary Technologies Approves Audited Financial Results for FY2026 and Appoints New Internal Auditors
Capillary Technologies India Limited announced the outcome of its Board Meeting held on May 06, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the company announced the appointment of M/s. Protiviti India Member Private Limited as its Internal Auditors for the Financial Year 2026-27.The company also issued an update regarding its trading window, noting that trading in its securities closed from April 01, 2026, and is scheduled to re-open 48 hours following the declaration of the financial results.
Financial Performance Overview (March 31, 2026)
The company released detailed financial statements, including audited standalone and consolidated results, alongside the statutory auditors' report.Consolidated Financial Results (in Indian Rupees (₹) million)
The audited consolidated financial results for the year ended March 31, 2026, demonstrate significant revenue figures across the reporting periods.| Particulars | Quarter Ended 31-Mar-26 (Audited) | Quarter Ended 31-Dec-25 (Unaudited) | Quarter Ended 31-Mar-25 (Unaudited) | Year Ended 31-Mar-26 (Audited) | Year Ended 31-Mar-25 (Audited) |
|---|---|---|---|---|---|
| I. Revenue from operations | 1,913.46 | 1,840.35 | 1,520.82 | 7,345.99 | 5,982.59 |
| II. Other income | 67.06 | 36.83 | 25.09 | 137.34 | 136.10 |
| III. Total income (I+II) | 1,980.52 | 1,877.18 | 1,545.91 | 7,483.33 | 6,118.69 |
| Total expenses | 1,599.47 | 1,590.60 | 1,245.47 | 6,417.48 | 5,332.96 |
| Profit before exceptional items and tax | 381.05 | 286.58 | 300.44 | 1,065.85 | 785.73 |
| Total tax expense | (8.89) | 1.28 | (10.66) | (12.78) | (34.72) |
| Total comprehensive income | 731.39 | 151.52 | 145.10 | 1,089.66 | 201.30 |
(Note: All amounts are in Indian Rupees (₹) million.)
Standalone Financial Highlights (in Indian Rupees (₹) million)
The standalone consolidated results showed the following total asset and equity positions:| Particulars | As at 31-Mar-26 | As at 31-Mar-25 |
|---|---|---|
| Total assets | 13,002.42 | 8,386.54 |
| Total equity | 10,234.93 | 5,682.47 |
| Total liabilities | 2,767.49 | 2,704.07 |
Governance and Audit Appointments
The Board of Directors approved the appointment of M/s. Protiviti India Member Private Limited to serve as the Internal Auditors of the Company for the Financial Year 2026-27. Protiviti India Member Private Limited is noted as a subsidiary of Robert Half International.Financial Statements Details
The company provided detailed tables of its annual financial results, balance sheets, and cash flow statements for review.Consolidated Balance Sheet (in Indian Rupees (₹) million)
| Particulars | As at 31-Mar-26 | As at 31-Mar-25 |
|---|---|---|
| Total assets | 13,002.42 | 8,386.54 |
| Total equity | 10,234.93 | 5,682.47 |
| Total liabilities | 2,767.49 | 2,704.07 |
Standalone Cash Flow Statement Summary (in Indian Rupees (₹) million)
| Particulars | For the year ended 31-Mar-26 | For the year ended 31-Mar-25 |
|---|---|---|
| Net cash generated from operating activities | 375.53 | 518.38 |
| Net cash used in investing activities | (3,542.63) | (702.79) |
| Net cash generated from financing activities | 3,253.44 | (406.99) |
| Cash and cash equivalents at the end of the year | 98.47 | 12.13 |
The company's managing director and CEO, Aneesh Reddy Boddu, confirmed the completion of the IPO, during which the company raised a total of ₹ 8,775.01 million. Out of this, ₹ 3,229.08 million was received net of IPO expenses, with ₹ 0.13 million utilized for the year ended March 31, 2026.
CAPILLARY Stock Price Movement
Shares of Capillary Technologies India Limited are edging higher to ₹584.8 as of 12:23 PM, gaining 8.14% in live trading. The equity has shown robust momentum today, trading within a notable range from ₹548 to ₹585.95.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: